RCWMU
ABBV icon

Rothschild & Co Wealth Management (UK)’s AbbVie ABBV Stock Holding History

Rothschild & Co Wealth Management (UK)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-326
Closed -$19K – 42
2015
Q4 		$19K Buy
+326
New +$18.8K ﹤0.01% 39
2015
Q3 		– Sell
-193
Closed -$13K – 41
2015
Q2 		$13K Buy
+193
New +$12.6K ﹤0.01% 50

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Rothschild & Co Wealth Management (UK)'s ABBV Position: Q1 2016 in Review

Rothschild & Co Wealth Management (UK) sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 326 shares — an estimated $19K sold.

Rothschild & Co Wealth Management (UK) first reported a position in ABBV in Q2 2015 and held it in 2 quarters. The position peaked at $19K in Q4 2015. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

  • Rothschild & Co Wealth Management (UK) reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
  • Rothschild & Co Wealth Management (UK) sold 326 AbbVie shares in Q1 2016, an estimated $19K.
  • Rothschild & Co Wealth Management (UK) first reported a position in AbbVie in Q2 2015 and held it in 2 quarters.
  • Rothschild & Co Wealth Management (UK)'s AbbVie position peaked at $19K in Q4 2015.
  • 1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Rothschild & Co Wealth Management (UK)'s 13F filing for Q1 2016, filed 19 Dec 2019.